GlassScriptPhysician profile
Gregory Lee Winger
NPI 1235661745
$5,200.13
in general payments reported to CMS, 2019-2025
38 companies · $1,128 in 2025
The $1,128 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $162 · 2021: $1,615 · 2022: $854 · 2023: $565 · 2024: $875 · 2025: $1,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,228.26 | 2021 | |
| Abbvie INC. | $1,040.62 | 2021-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $361.25 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $358.49 | 2020-2025 | Krystexxa, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.52 | 2020-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $252.89 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $207.58 | 2020-2025 | Airsupra, Farxiga, Flumist Quadrivalent |
| Biohaven Pharmaceutical Holding Company LTD. | $152.09 | 2022 | |
| Boston Scientific Corporation | $141.70 | 2022-2025 | Artisan, Watchman Access System, Watchman Flx |
| Glaxosmithkline, LLC. | $138.06 | 2021-2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $126.99 | 2020-2024 | Spravato |
| Novartis Pharmaceuticals Corporation | $108.36 | 2022 | |
| Merck Sharp & Dohme LLC | $79.19 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $66.14 | 2024 | Gemtesa |
| Sanofi Pasteur INC. | $55.55 | 2023-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $48.12 | 2024-2025 | Nexplanon |
| Jazz Pharmaceuticals INC. | $47.45 | 2022 | |
| Novo Nordisk INC | $44.90 | 2021-2022 | |
| Lucid Diagnostics INC. | $44.73 | 2023 | |
| Exact Sciences Corporation | $43.53 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Horizon Therapeutics Plc | $38.66 | 2023 | Krystexxa |
| Axsome Therapeutics, INC. | $33.04 | 2022-2023 | Sunosi |
| Nevro Corp. | $30.53 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $27.26 | 2025 | |
| Grifols USA, LLC | $22.36 | 2024 | Prolastin-C Liquid |
| Aimmune Therapeutics, INC. | $21.70 | 2024 | |
| Galderma Laboratories, L.P. | $18.47 | 2025 | Nemluvio |
| Rgh Enterprises LLC | $18.00 | 2025 | |
| Amarin Pharma, INC. | $16.52 | 2020 | |
| Currax Pharmaceuticals LLC | $15.82 | 2021 | |
| Dexcom, INC. | $15.40 | 2025 | Dexcom G6 Transmitter |
| Ultragenyx Pharmaceutical INC. | $14.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.91 | 2021 | |
| Harmony Biosciences LLC | $13.56 | 2022 | |
| Optinose US, INC. | $13.07 | 2024 | |
| Neurelis, INC. | $12.81 | 2023 | Valtoco |
| Medtronic, INC. | $11.85 | 2022 | |
| Daiichi Sankyo INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Winger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.